Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(2)
MIXED(1)
Flonoltinib 100mg
1 trial
phase_2
chengdu-zenitar-biomedical-technology-co-ltd
Ruxolitinib
1 trial
phase_2
chengdu-zenitar-biomedical-technology-co-ltd
Flonoltinib 50mg
1 trial
phase_2
chengdu-zenitar-biomedical-technology-co-ltd
3 unique interventions2 categories

Analytics

Trial Phases

Phase 21

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT06457425Phase 2Active Not Recruiting
A Phase II Clinical Trial of Flonoltinib Maleate Tablet in Intermediate-High Risk Myelofibrosis
MF,PMF,PPV-MF,PET-MF
PrincipalinvestigatorStart date: 2024-05-06

Research Network

Collaboration Network

6 collaborators·5 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Therapeutic Areas

MF,PMF,PPV-MF,PET-MF1

Affiliations

Hematology Hospital, Chinese Academy of Medical Sciences

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

1 similar investigators found

ting Niu, doctor

West China Hospital

Related
7 trials

Shared therapeutic areas:

MF,PMF,PPV-MF,PET-MF

Worked with same sponsors:

Chengdu Zenitar Biomedical Technology Co., Ltd
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT06457425Phase 2PrincipalInvestigator

A Phase II Clinical Trial of Flonoltinib Maleate Tablet in Intermediate-High Risk Myelofibrosis

MF,PMF,PPV-MF,PET-MF
Active Not Recruiting

All 1 trials loaded